Low Back Pain: Pharmacological Treatments – Cochrane Reviews
Explore the latest Cochrane Reviews and discover effective pharmacological treatments for lower back pain. This comprehensive analysis of 103 studies, involving over 22,000 participants, unveils critical findings for both acute and chronic lower back pain sufferers. Learn how paracetamol stacks up against placebos and the benefits—and risks—of NSAIDs and muscle relaxants. The review dives deep into the efficacy of opioids, including tapentadol and tramadol, for chronic pain management, while also assessing the role of antidepressants. What medications truly offer relief, and which ones fall short? News Directory 3 offers insight into the latest evidence-based approaches to pain relief. Understand the nuances of pharmacological interventions,from acute to chronic conditions. Discover what’s next in lower back pain management as researchers delve deeper, focusing on long-term effects and personalized treatments.
Medications for Back Pain Relief: what Works?
Updated May 27,2025
A extensive review of 103 studies involving 22,238 participants examined the effectiveness of various medications for lower back pain (LBP). the analysis, encompassing seven Cochrane Reviews, assessed treatments for both acute and chronic LBP, focusing on pain intensity, disability, and adverse events.
The review considered six classes of medications: paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, benzodiazepines, opioids, and antidepressants. findings varied depending on whether the LBP was acute or chronic.
Acute Lower Back Pain Treatments
For acute LBP, the review found high-certainty evidence that paracetamol offers no significant benefit over placebo in reducing pain or disability. NSAIDs, though, showed a small but statistically significant advantage in reducing pain and disability, though the risk of adverse events was not considerably increased.
Muscle relaxants and benzodiazepines were found to offer a slightly better chance of pain relief and improved physical function compared to placebo, but also carried a higher risk of adverse events.
Notably, the review did not identify any evidence regarding the use of opioids or antidepressants for acute LBP.
Chronic Lower Back Pain Treatments
In cases of chronic LBP, paracetamol showed no identified benefits. NSAIDs, however, demonstrated a small advantage over placebo in reducing pain and disability at intermediate-term follow-up, without a significant increase in adverse events.
Benzodiazepines showed a slightly higher chance of pain relief compared to placebo, while muscle relaxants showed no difference in the risk of adverse events. Opioids, including tapentadol, tramadol, and buprenorphine, showed varying degrees of effectiveness in reducing pain and disability, but were also associated with an increased risk of adverse events such as nausea, headaches, constipation, and dizziness.
Antidepressants showed no significant difference compared to placebo in reducing pain or disability in individuals with chronic LBP.
What’s next
Further research is needed to explore long-term effects and optimal use of medications for managing lower back pain, considering individual patient characteristics and preferences.